# Metformin in Women With Type 2 Diabetes in Pregnancy Trial

Study · id `cardio:ct-nct01353391` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01353391](<https://clinicaltrials.gov/study/NCT01353391>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01353391

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 500 participants.

## Technical summary

Registry record NCT01353391. Randomized; quadruple masking; primary purpose treatment. Start 2011-05-25 (actual); primary completion 2019-06-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 500 participants (enrolled count; ClinicalTrials.gov record NCT01353391, source copy `cardio:ctgov-nct01353391-2020-03-03`, retrieved 2026-10-26)
- Started: 2011-05-25 (actual) (ClinicalTrials.gov record NCT01353391, source copy `cardio:ctgov-nct01353391-2020-03-03`, retrieved 2026-10-26)
- Primary completion: 2019-06-05 (actual) (ClinicalTrials.gov record NCT01353391, source copy `cardio:ctgov-nct01353391-2020-03-03`, retrieved 2026-10-26)
- Completion: 2019-06-05 (actual) (ClinicalTrials.gov record NCT01353391, source copy `cardio:ctgov-nct01353391-2020-03-03`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01353391, source copy `cardio:ctgov-nct01353391-2020-03-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01353391-2020-03-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Metformin in Women With Type 2 Diabetes in Pregnancy Trial
- Acronym: MiTy
- Condition: Type 2 Diabetes
- Intervention (Drug): Metformin
- Intervention (Drug): Placebo Comparator
- Lead sponsor: Mount Sinai Hospital, Canada
- Lead sponsor class: OTHER
- Collaborator: University Health Network, Toronto
- Collaborator class: OTHER
- Collaborator: Sunnybrook Research Institute
- Collaborator class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Mount Sinai Hospital, Canada (`cardio:org-mount-sinai-hospital-canada`)
- Registry lists this organization as a collaborator: University Health Network, Toronto (`cardio:org-university-health-network-toronto`)
- Registry lists this organization as a collaborator: Sunnybrook Research Institute (`cardio:org-sunnybrook-research-institute`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial (`cardio:pubmed-32946820`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9d30be92cf2df92a035b9be8b3cd8bf604a8548946f4a24b326308c8855e9fd7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
